Originally published In Press as doi:10.1074/jbc.M201390200 on April 5, 2002
J. Biol. Chem., Vol. 277, Issue 25, 22829-22838, June 21, 2002
The Caenorhabditis elegans Gene,
gly-2, Can Rescue the
N-Acetylglucosaminyltransferase V Mutation of Lec4
Cells*
Charles E.
Warren
,
Aldis
Krizus
,
Peter J.
Roy
§¶,
Joseph G.
Culotti
§, and
James W.
Dennis
§
From the
Samuel Lunenfeld Research Institute, Mount
Sinai Hospital, Toronto, Ontario M5G 1X5 and § Department
of Molecular and Medical Genetics, University of Toronto, Toronto,
Ontario, M55 1A8, Canada
Received for publication, February 11, 2002, and in revised form, March 28, 2002
 |
ABSTRACT |
UDP-N-acetylglucosamine:
-6-D-mannoside
-1,6-N-acetylglucosaminyltransferase V (GlcNAc-TV) is a
regulator of polylactosamine-containing N-glycans and is
causally involved in T cell regulation and tumor metastasis. The
Caenorhabditis elegans genome contains a single orthologous
gene, gly-2, that is transcribed and encodes a 669-residue type II membrane protein that is 36.7% identical to mammalian GlcNAc-TV (Mgat-5). Recombinant GLY-2 possessed GlcNAc-TV
activity when assayed in vitro, and protein truncations
demonstrated that the N-terminal boundary of the catalytic domain is
Ile-138. gly-2 complemented the Phaseolus
vulgaris leucoagglutinin binding defect of Chinese hamster ovary
Lec4 cells, whereas GLY-2(L116R), an equivalent mutation to that
which causes the Lec4A phenotype, could not. We conclude that
the worm gene is functionally interchangeable with the mammalian form.
GlcNAc-TV activity was detected in wild-type animals but not those
homozygous for a deletion allele of gly-2. Activity was
restored in mutant animals by an extrachromosomal array that
encompassed the gly-2 gene. Green fluorescent
protein reporter transgenes driven by the gly-2 promoter
were expressed by developing embryos from the late comma stage onward,
present in a complex subset of neurons in larvae and, in addition, the spermathecal and pharyngeal-intestinal valves and certain vulval cells
of adults. However, no overt phenotypes were observed in animals
homozygous for deletion alleles of gly-2.
 |
INTRODUCTION |
UDP-N-acetylglucosamine:
-6-D-mannoside
-1,6-N-acetylglucosaminyltransferase V
(GlcNAc-TV)1 is one of a set
of sequence-unrelated GlcNAc-T enzymes that create branches in
complex-type N-glycans (1). These branches can be further
elongated by galactosyltransferase and other enzymes to create the
mature glycoprotein oligosaccharides. The GlcNAc
1,6 branch resulting
from GlcNAc-TV action is distinct in that it is the preferred site for
elongation with polylactosamine chains, repeating lactosamine units
that themselves can be further branched and carry a variety of terminal
structures. GlcNAc-TV is thus a potential regulator of polylactosamine
containing N-glycan chains on target glycoproteins.
GlcNAc-TV is also distinct from the other N-acetylglucosaminyltransferases in that it has a specific
temporal and spatial expression pattern in the developing mouse embryo. Expression is concentrated in neuronal tissues, specialized epithelium, and regions with stem cell-like populations. Zygotic expression increases at about 9.5 days post coitus, which coincides with the onset
of organogenesis (2).
Mice deficient in GlcNAc-TV activity through mutation of the
Mgat-5 locus are viable but develop glomerulonephritis with
age, which is associated with T cell hypersensitivity, apparently as a
result of altered activation kinetics of the T cell receptor complex
(3). When the Mgat-5o allele is combined with a
mouse mammary tumor virus-promoted Polyomavirus
middle T antigen transgene, multifocal tumorigenesis is delayed, and
metastasis caused by the Polyomavirus middle T antigen is
dramatically suppressed (4). This result is consistent with prior
observations that tumor cell lines selected by resistance to the
cytotoxic lectin Phaseolus vulgaris leucoagglutinin
(L-PHA) deficient in GlcNAc-TV also failed to metastasize
in syngeneic mice (5).
Although the Mgat-5o mouse is highly
informative, systematic analysis of a complex viable phenotype remains
difficult, particularly the identification of the dependent molecules
and pathways. We therefore sought a simpler model organism in which
synthetic genetics could be carried out rapidly to characterize the
complex pleiotropic phenotypes expected from disruption of the
glycosylation machinery. Because of the cellular non-autonomy typical
of glycosylation phenotypes and of the phylogenetic restriction of
complex-type N-glycans to metazoans, a whole animal model is
necessary. Caenorhabditis elegans is the simplest and most
highly characterized animal, its adult anatomy and developmental
lineage have been completely determined (6, 7), and its genome is
essentially completely sequenced (8). C. elegans is highly
tractable to experimental phenotypic and genetic analysis, and there
are numerous examples demonstrating that genetic pathways found in
mammals are also conserved in this nematode (9-13). Surveys of the
C. elegans genome sequence revealed a coding potential for
most known glycosyltransferase genes (14). Genes encoding active
polypeptide GalNAc-transferases (15), GlcNAc-TI (16), and a
fucosyltransferase (17) have been characterized. In addition, there are
at least three sqv genes that are elements of a proteoglycan
glycosylation pathway that when mutated cause severe and pleiotropic
defects (18-21). A recent NMR-mass spectrometry study identified the
abundant N- and O-glycans in C. elegans (22). The canonical oligomannose series of
N-glycans were observed, but atypical O-glycans
were found where polypeptide linked GalNAc was
1-6-branched as in mammals but substituted with glucose or galactose rather than GlcNAc.
We characterized the 6 homologues of core 2 GlcNAc-T (23) and
demonstrated that gly-1 transfers glucose from UDP-glucose to core 1 acceptor consistent with the inference based on the structural analysis (24).
We observed that the C. elegans genome encodes a single
gene, designated gly-2, which is homologous to mammalian
GlcNAc-TV sequences. In this paper, we establish that the nematode
orthologue is functionally equivalent to that from mammals and that
C. elegans is an appropriate model in which to pursue
investigations of the contributions to fitness made by
6-GlcNAc-branched N-glycans.
 |
EXPERIMENTAL PROCEDURES |
Strains and Materials--
Primer sequences (ACGT Corp.) are
available on request. The wild-type Bristol strain of C. elegans (N2) (25) and him-5(e1490) were
available as laboratory stocks. CB1282
dpy-20(e1282) IV, DR466
him-5(e1490) V, and DR435
dpy-5(e61) unc-13(e51)
I were supplied by T. Stiernagle (C. elegans
Genetics Center, University of Minnesota). BC107
bli-4(e937), dpy-14(e188)
I was the gift of Dr. D. Baillie (Simon Fraser University,
Vancouver, Canada). Standard husbandry methods were used (7,
26). Cosmid C55B7 was obtained from Dr. A. Coulson (Sanger Centre,
Cambridge, UK). pPD95.77 and pPD95.69 were from Dr. A. Fire (Carnegie
Institute of Washington), pMH#6 was obtained from Dr. M. Han
(University of Colorado), pRF4 originated in the laboratory of Dr. J. Kramer (Northwestern University Medical School), and pIMKF1 was the
gift of Dr. F. Hagen (University of Rochester Medical School). pCMVCD20 was obtained from Dr. E. Harlow (Massachusetts General Hospital Cancer
Center), and Dr. P. Stanley provided pLec4 and pCHO-K1 (Albert Einstein
College of Medicine). The C. elegans EST cm20c4 (GB:M89265)
was provided by Dr L. Hillier (Washington University Genome Sequencing
Center), and yk126h8 (GB:D64875/D68132) was obtained from Dr. Y. Kohara
(National Institute of Genetics, Mishima, Japan). The GlcNAc-TV
acceptor,
GlcNAc(1,2)
Man(1,6)
Glc-O(CH2)7CH3, was a gift from Glycodesign Inc.
Molecular Biology Procedures--
Unless otherwise noted,
standard molecular biology techniques were employed (27).
5' RACE--
Poly(A)+ RNA was isolated from mixed
populations of C. elegans using a QuickPrep Micro mRNA
purification kit (Pharmacia). The 5' RACE system (Invitrogen) was used
according to the manufacturer's instructions. First strand cDNA
synthesis was primed with yk5'rc0. First round PCR using AmpliTaq Gold
(PerkinElmer Life Sciences) was primed with yk5'rc1. The second round
PCR used Pfu DNA polymerase (CLONTECH)
and yk5'rc2 as the gene-specific primer. Amplimer was sequenced
directly and subcloned into the EcoRV site of pZErO-2 (Invitrogen). Independent recombinants were analyzed by colony PCR
using SL1, SL2, or RACE anchor and yk5'rc2 primers.
Northern Analysis--
Non-starved mixed stage animals from
Bristol N2 and him-5(e1490) strains were used to
prepare poly(A)+ RNA using a Dynabeads kit (Dynal A. S.) after disruption in a Polytron (Kinematica). ~1 µg of mRNA
was fractionated, blotted, probed with the
-32P-labeled
SalI/SmaI fragment of yk126h8, and analyzed with
a PhosphorImager (Storm/ImageQuant, Molecular Dynamics).
Construction of Mammalian Expression Vectors--
pISTH1 was
constructed from pIMKF1 (15) by replacing the
NdeI-BamHI segment upstream of the cloning site
with an NdeI-BglII fragment from pCITE4b(+)
(Novagen). N-terminal truncations of GLY-2 were generated by PCR from
yk126h8 as template using Pfu DNA polymerase primed by
yk*670r and one of ykI28f, gly2-
133, gly2-
137, or gly2-
138. Amplimers were subcloned into the
EcoRV site of pZErO-2 (Invitrogen) and sequenced.
BamHI fragments of error-free subclones were ligated into
the BamHI site of pISTH1. Ligation junctions, frame, and
orientation were checked by DNA sequencing. A yk5'rc2 and SL1-primed
TaqDNA polymerase PCR product of the RACE amplimer was
subcloned into EcoRV cut and T-tailed pGEM5zf(+) (Promega)
forming pYS. pCDNA3::yk126h8(+) was created by subcloning
the PvuII-SmaI fragment of yk126h8 into
EcoRV cut pCDNA3 (Invitrogen). An expression construct
for mature SL1 trans-spliced cDNA (pCSYK-1) was
constructed by combining the SpeI-NarI fragment of pYS with the NarI-NotI fragment of
pCDNA3::yk126h8(+) in SpeI-NotI-cut pZErO-2, the BamHI-NotI fragment of which
was subcloned into pCDNA3. The amplified region and ligation
junctions were checked by DNA sequencing. The GLY-2(L116R) mutation was
introduced into pCSYK-1 by mutagenesis directed by primer GLY2-L116R
using the Chameleon kit according to the manufacturer's instructions
(Stratagene). The complete transcriptional unit of the resulting
construct, pCSYK-L116R, was sequenced. pEGFP-GLY2 was constructed by
subcloning the ykR2f-yk*670r product generated
by PCR amplification with Pfu DNA polymerase from yk126h8
template into the BamHI site of pEGFP-C3
(CLONTECH). The insert and ligation junctions were
completely sequenced and found to be in-frame and error-free.
pEGFP-L116R was derived by replacing the
BstXI-EcoRV fragment with the equivalent section
of pCSYK-L116R to generate pEGFP-L116R. The introduced segment was
confirmed by sequencing.
Transient Expression and Secretion of GLY-2 in Lec4
Cells--
3 × 105 Lec4 cells (ATCC) were plated in
each well of 6-well tissue culture clusters (Costar). The following
morning, 1 µg of DNA (QIAgen) of pISTH1-based truncation constructs
were transfected at 37 °C in a humidified 5% CO2
atmosphere for 5-6 h using 8 µl of LipofectAMINE (Invitrogen) in 1 ml of OptiMEM-I (Invitrogen)/well. One ml of
-minimal essential
medium containing 20% fetal bovine serum was added to the
wells, and the clusters were transferred to a humidified 5%
CO2 atmosphere at 30 °C overnight. The following day,
well contents were aspirated and replaced with 2 ml of
-minimal essential medium containing 10% fetal bovine serum, and incubation was
continued until 78 h post-transfection. Conditioned medium was
clarified by centrifugation at 1800 × g for 10 min and
stored at 4 °C after the addition of sodium azide to 0.05% w/v.
Immunopurification of Recombinant Proteins--
Recombinant
proteins directed by pISTH1-based plasmids bear an N-terminal S-tag
that was assayed according to the manufacturer's instructions in
conditioned media from the transient transfections (Novagen). 1.25 pmol
of recombinant protein in conditioned medium was immunoprecipitated and
diluted into 1 ml of dilution buffer (10 mM Tris-HCl, pH
8.0, 150 mM NaCl, 0.025% w/v NaN3, 0.1% v/v Triton X-100, 0.1% w/v bovine serum albumin). Aliquots were
preadsorbed with 35 µl of a 50% v/v slurry of goat anti-rabbit IgG
polyclonal antibody-agarose (Sigma) overnight at 4 °C then
centrifuged briefly before supernatants were transferred to fresh
tubes. 1 µg of rabbit polyclonal anti-S-tag antibody and a fresh
aliquot of anti-rabbit IgG polyclonal antibody-agarose were added for
2 h at 4 °C before the beads were pelleted by centrifugation at
3000 rpm for 10 s in a microcentrifuge. Beads were washed 3 times with 1-ml aliquots of dilution buffer before 3 more washes with
100 mM MES, pH 6.5, 0.1% v/v Triton X-100, 100 µg/ml
bovine serum albumin. A final aspiration of supernatant left the beads
as a 50% slurry in a total volume of 35 µl, which was used for assay
of GlcNAc-TV enzyme activity.
Assay of GlcNAc-TV Enzyme Activity--
Enzyme activity was
measured using synthetic specific acceptors (28). Assays contained 1 mM
GlcNAc(1,2)
Man(1,6)
Glc-O(CH2)7CH3 acceptor, 1 mM [6-3H]UDP-GlcNAc (44,400 dpm/nmol) in 50 mM MES, pH 6.5, in total volumes between 30 and 100 µl. Enzyme sources were nematode microsomal membranes, cell
lysates, conditioned media either directly or dialysates against 10 mM MES, pH 6.0, or immunoprecipitates. Assays using
microsomal membranes contained 2 mM acceptor and donor, both, which was 105 dpm/nmol. In addition these samples
contained 5 mM adenosine 5'-monophosphate and 500 µM 2-acetamido-1,2-dideoxynojirimycin (Toronto Research
Chemicals). After 3 h at the appropriate incubation temperature, 1 ml of ice-cold water was added to stop further reaction, and assays
were either frozen or processed immediately. Enzyme products were
separated from radioactive substrates by binding them to 50 mg of
C18 cartridges (Alltech) preconditioned with methanol
rinsing and water washing. Reactions were loaded, and the columns were
washed 5 times with 1 ml of water. Radiolabeled products were eluted
directly into scintillation vials with 2 separately applied 0.5-ml
aliquots of methanol, and the radioactivity was determined by liquid
scintillation counting.
Fluorescence Analysis of Lec4 Cells Transfected with
gly-2--
Transient transfections were performed essentially as above
except that Lec4 or CHO-K1 cells were plated at 106 cells
on 6-cm tissue culture dishes (Falcon) that were cotransfected with 0.5 µg of pCMVCD20 (29) and 2.5 µg of pLec4, pCHO-K1, pCSYK-1, or
pCSYK-L116R DNA using 18 µl of LipofectAMINE in 3 ml of OptiMEM-I. At
71 h post-transfection, the media were aspirated, and the plates were rinsed with ice-cold PBS followed by ice-cold PBS, 0.1% w/v EDTA
(PBSE). Cells were dissociated from the dish by incubation in 0.5 ml of
PBSE for 10 min at room temperature before triturating with 4.5 ml of
PBS, 1% v/v fetal bovine serum, 0.1% w/v NaN3 (PBSFN). Aliquots of 1.2 × 106 transfected cells were
transferred to 6-ml polypropylene tubes (Falcon) on ice, filled with
PBSFN, and centrifuged at 500 × g for 5 min at
4 °C, and the supernatants were decanted. FITC-conjugated L-PHA (Sigma) was preadsorbed against Lec4 cells by
incubating 40 µg of FITC-L-PHA with 4 × 107 untransfected Lec4 cells (harvested using PBSE) in a
total volume of 800 µl of PBSFN for 15 min on ice, then clarified.
Lec4-absorbed FITC-L-PHA (0.5 µg) and 10 µl of
phycoerythrin-conjugated monoclonal anti-CD20 (BD PharMingen) were
added to each sample, and the cells were resuspended. After a 30-min
incubation on ice, tubes were filled with PBSFN and centrifuged at
500 × g for 5 min at 4 °C, and the supernatants
were decanted. Washes were repeated twice more before a final
resuspension in 1 ml of PBSFN. FACS was carried out on a FACStar (BD
PharMingen). Live single cells were selected based on a forward and
side scattering gates, and data acquisition and analysis used the
CellQuest package. Transfected cells were gated based on the
phycoerythrin anti-CD20 fluorescence, and the FITC L-PHA
staining of at least 104 transfected live single cells was
measured for each sample. 3 µg of pEGFP-C3, pEGFP-GLY2, or
pEGFP-L116R were transfected into Lec4 or CHO-K1 similarly. After
harvesting, cells were stained with 2 µg of biotinylated
L-PHA (Sigma), washed four times with PBSFN, then developed
with 1 µg of streptavidin-CyChrome (BD PharMingen). After 3 washes
with PBSFN, CyChrome staining of 2 × 104 transfected
GFP+ cells was measured for each sample. The remaining
cells after analysis were immediately washed twice in PBS before cell
pellets were flash-frozen and stored at -70 °C. Cell pellets were
lysed in 50 mM MES, pH 6.5, 0.5% v/v Triton X-100, 10 mM EDTA containing 1× Complete protease inhibitor mixture
(Roche Molecular Biochemicals). After 5 min on ice, lysates were
clarified at 14,000 rpm for 5 min in a microcentrifuge, and
supernatants were transferred and assayed immediately for GlcNAc-TV activity.
Western Analysis--
Conditioned media from Lec4 cells that had
been transiently transfected with pISTH1-based truncation constructs
were subjected to SDS-PAGE, electroblotted to polyvinylidene difluoride
(Waters), and blocked with TBS, 0.1% v/v Tween 20, 5% skimmed milk
(TBSTM). Filters were washed with TBS, 0.1% v/v Tween 20 (TBST), then
incubated with 0.5 µg/ml polyclonal rabbit anti-S-tag
(CLONTECH) at 4 °C overnight. The blot was
washed again with TBST then developed with 1:12,500 horseradish
peroxidase-conjugated donkey anti-rabbit Ig (Amersham Biosciences) in
TBST for 2 h at room temperature before extensive washes with TBST
then TBS and visualization of the signal by ECL (Amersham Biosciences),
recorded using X-Omat Blue XB-1 film (Eastman Kodak Co.). Clarified
lysates prepared from samples that had been subjected to FACS analysis
and GlcNAc-TV assay were separated by electrophoresis in a MOPS buffer
system on 4-12% BisTris NuPage gels (Novex) then electroblotted as
above. After methanol washing and air-drying, filters were incubated with 1:5000 monoclonal anti-GFP (CLONTECH) in TBSTM
for 30 min at room temperature. After 5 rinses in TBS, the blot was
developed with 1:2000 horseradish peroxidase-conjugated sheep
anti-mouse Ig (Amersham Biosciences) in TBSTM. After 5 rinses and a
15-min wash in TBS, chemiluminescence signals (Supersignal, Pierce)
were recorded.
GFP Reporter Transgenes--
The 7461-bp NsiI
fragment of C55B7 was subcloned into the PstI site of
pPD95.69 and pPD95.77. A partial NarI digest was performed, and the overhangs were blunted (Klenow). A SmaI digestion
was used to excise the intervening fragment, and the construct was reclosed. The ligation junctions were found to be correct after DNA sequencing. This procedure created an in-frame fusion between the
NarI site in codon 3 of GLY-2 and the GFP segment of the
vector, preceded by 6.7 kbp of upstream genomic DNA corresponding to
bases 19,280 to 25,991 of C55B7. CB1282 hermaphrodites were transformed by gonad injection (30) of a mixture of reporter construct and pMH#6, a
plasmid containing a region of C. elegans genomic DNA capable of rescuing the dpy-20(e1282) mutation.
Several non-Dpy F1 progeny were selected for each reporter construct,
transgenic lines were established from them, and epifluorescence
microscopy was performed using a Leica DMR photomicroscope. The
inheritance of extra-chromosomal arrays is mosaic, and the fine
structure of the array in each strain is different. Consequently,
several individuals from each line were examined to compile consensus expression patterns. Cell identification was accomplished using the
position and morphology of the expressing cells, the number and
position of their nuclei, and by comparison to anatomical landmarks
visualized by differential interference contrast microscopy.
Mutagenesis--
The gly-2 alleles, ev581,
and qa700 were generated by Tc1-mediated mutagenesis with
minor modifications (31). qa703 was isolated from
ethylmethanesulfonate-induced deletion libraries using minor variances
from published procedures (32). Tc1 mutagenesis relies on transposon
mobilization, so the founding strain contains mut-2 alleles.
Animals bearing qa700 were therefore crossed eight times
with N2 before out-crossing with BC107 and recombination of the
dpy-14 locus with gly-2 to break the chromosome
between gly-2 and mut-2. This strain was then
further out-crossed an additional 4 times with N2 to remove the
dpy-14 allele and create strain XA728
gly-2(qa700**14) I. qa703-bearing animals were
crossed three times with N2 then with DR435 to recombine the
mutagenized chromosome with wild-type material either side of
gly-2. dpy-5(e61),
gly-2(qa703), and unc-13(e51) I
animals were derived and subsequently crossed another 5 times with N2
to remove the markers and generate strain XA762
gly-2(qa703**10) I. Both alleles were mapped by
recombination frequencies with dpy-5 and unc-13
using PCR to score for the presence of the qa700 or qa703 alleles. The
deletion boundaries of the alleles were characterized by sequencing DNA
that had been PCR-amplified from genomic DNA using primers that
encompassed the deletions.
Genetic Mapping of gly-2--
DR435 hermaphrodites were mated
with XA728 males, and cross-progeny hermaphrodites were picked and
allowed to segregate F2. Animals carrying chromosomes that had
recombined between the dpy-5 and unc-13 loci were genotyped by
single-worm PCR (26) using primer sets that specifically detected
wild-type and deletion alleles to determine the frequency of
recombination between gly-2 and both marker loci,
dpy-5 and unc-13. Of 26 Dpy non-Unc chromosomes, 15 recombinations occurred in the dpy-5-gly-2 interval, and
of 28 Unc non-Dpy chromosomes, 13 recombinations occurred between gly-2 and unc-13.
Construction of Precomplementation Lines--
The 13,806-bp
XbaI fragment corresponding to bases 17,188-30,994 of
cosmid C55B7 was subcloned into the XbaI site of
pZErO-2 to create pResLng-9E, and the structure was verified by
restriction digests. This genomic region encompassed all
gly-2 sequences detected in transcripts as well as an
additional 4248 bases upstream of the 5' limit of yk126h8 and 1281 bases downstream of the site of polyadenylation. XA762 hermaphrodites
were transformed by gonad injection (30) of a mixture of pResLng-9E and
pRF4, a plasmid containing a region of C. elegans genomic
DNA carrying the rol-6(su1006) mutation that acts dominantly
by causing animals bearing the array to roll. Several independent
rolling lines were established, and the percentage of rolling
self-progeny from each was characterized. GlcNAc-TV activity was
assayed using microsomal membranes prepared from 2 such lines, XA766
gly-2(qa703) I; qaEx743[gly-2(+),
rol-6(su1006)] and XA768 gly-2(qa703) I;
qaEx745[gly-2(+), rol-6(su1006)], both of which
transmitted the array to 30-50% of their progeny.
Microsomal Membrane Preparation--
Cultures were established
by picking 50 rolling L4 hermaphrodites (or 20 animals from
non-transgenic lines) to each of 5 100-mm diameter complete
nematode growth medium plates that were then grown at room temperature
until the animals cleared the Escherichia coli OP50 lawn.
Nematodes were rinsed from the plates in cold 100 mM NaCl,
washed twice, then floated on sucrose (60% w/v). After 2 washes with
100 mM NaCl, the pellet was snap-frozen in an ethanol-dry
ice bath and stored at
70 °C. Samples were thawed by adding 1 ml
of TSEC (20 mM Tris-HCl, 250 mM sucrose, 1 mM EDTA, 1× CompleteTM; Roche Molecular
Biochemicals) then sonicated on ice 5 times using a 10-s pulse before
dilution with a further 3 ml of TSEC. After centrifugal clarification
for 10 min at 3000 rpm at 4 °C (Sorval RT6000), the supernatant was
ultracentrifuged at 55,000 rpm for 1 h at 4 °C (Beckman L8-80
M with a 70.1Ti rotor). The microsomal pellet was suspended in a
minimal volume of 100 mM MES, pH 6.5, 2% v/v Triton X-100,
2× CompleteTM, 20 mM EDTA, the protein
concentration was determined by BCA assay (Pierce) standardized with
bovine serum albumin, then 386 µg of each preparation was subjected
immediately to GlcNAc-TV assay.
 |
RESULTS |
The gly-2 Gene of C. elegans--
TBLASTN queries of the
GenBankTM dBEST data base using rat GlcNAc-TV polypeptide
(GB:AAA41665) revealed two homologous C. elegans ESTs,
cm20c4 and yk126h8 (33),2
which were obtained and sequenced (Fig.
1). A single reverse transcriptase-specific product after 5' RACE was observed, and direct sequencing revealed a trans-spliced SL1 sequence
attached to position
14, where a splice acceptor site occurs
immediately upstream in the genomic sequence. Comparison of the genomic
and yk126h8 sequences confirms an intron at this point. All 35 independent subclones of the RACE product that were tested for the
presence of SL1 and SL2 sequences by colony PCR and 5 that were
sequenced contained SL1. This transcript structure is concordant with
the Northern analysis that indicated a single poly(A)+ RNA
species of ~2.25 kb (Fig. 2).
Comparison of the cDNA and genomic sequences indicates that the
gene organization is typical, with 10 exons of 82-589 bp separated by
44-882 bp of introns (Fig. 3A) (34). Notably, the
majority of the exon boundaries in human and C. elegans
genes occurs at equivalent residues, and in most cases, the phase is
conserved too. We named the gene gly-2 as a member of the
GLYcosylation class. BLAST searches using the cDNA or
deduced polypeptide sequences revealed that the C. elegans genome contains a single homologous region, implying that
gly-2 is the nematode orthologue of GlcNAc-TV.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 1.
The sequence of gly-2
cDNAs. A, 5'-untranslated region of EST
yk126h8 that is absent in the major gly-2 mRNA.
B, cDNA sequence and inferred polypeptide of mature
gly-2 mRNA numbered relative to the initiator residues.
SL1 is trans-spliced to nucleotide 14. The start of EST
cm20c4 is also indicated. Initiator and stop codons are shown in
bold. The putative TMD is double-underlined. Potential
N-linked glycosylation sites are
single-underlined. The consensus polyadenylation signal is
boxed. The run of eight adenines preceding the
poly(A) (An) indicator is present in the genomic
sequence. It is therefore not clear where transcription terminates
precisely.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Northern analysis of poly(A)+ RNA
from C. elegans strains Bristol N2 and CB1490
him-5(e1490) probed with the
SalI-SmaI fragment of yk126h8.
The data represent one of two independent experiments. The
arrows indicate migration positions of size markers and the
residual ribosomal RNAs in the preparations. The origins are marked by
radioactive pencil lines at the top.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Genomic structure and alignment detail of
gly-2 with mammalian homologues. A,
inferred genomic structure of gly-2 by comparison of
cDNA and genomic sequence (cosmid C55B7, GB:AC006625,
top) and human GlcNAc-TV cDNA and genomic sequence (52),
GB:D17716 (53) and GB:S80050, bottom). Dashed
lines indicate the alignment of the first amino acid of the
C. elegans exons with the corresponding aligned residue in
the human sequence. The double-headed arrow shows the
position of the mislocalization mutations, and the exon containing the
conserved stretch around this leucine is shaded light gray.
The darker gray exons are those comprising the catalytic
domains. The phase of each intron is indicated by the digits
0, 1, or 2. Note that the intron
scaling for the human sequence is different. Non-coding exons or
portions are unshaded. The regions deleted by alleles qa700 and qa703
are demarcated with "I" bars. B, detail of the
alignment between Ce-GLY-2 and CHO cell GlcNAc-TV (35) (GB:U62587).
Mislocalization is caused by mutation of the emboldened leucine. The
island of conservation surrounding this residue is
underlined. The triangles indicate the in-frame
boundary residues between exons. The arrows indicate the
positions of truncations 133, 137, and 138.
|
|
The conceptual translation of the open reading frame encodes a
669-amino acid polypeptide that is 59.9% similar and 36.7% identical
to rat GlcNAc-TV. When the sequence was queried against GenBankTM using BLAST, only mammalian GlcNAc-TV sequences
were returned as significant hits. There are five potential
N-linked glycosylation sites, but they are not conserved
with the mammalian homologues. Hydropathy plots indicated that GLY-2 is
a type II membrane protein with the secondary structural
characteristics of Golgi glycosyltransferases (Fig.
4A). This plot reveals four
distinct regions in GLY-2; a hydrophilic cytosolic tail precedes the
putative TMD, whereas the lumenal part of the molecule consists of a
consistently hydrophilic 112 residue stretch before an amphiphilic
C-terminal portion. Consistent with this model, alignments between
GLY-2 and mammalian homologues showed increased conservation in the
C-terminal portion of the molecule (Fig. 4B). A conserved
peptide (C110-P124) lies in the otherwise
diverged stem that encompasses a conserved leucine residue equivalent
to that mutated in the GlcNAc-TV gene of Lec4A cells (Fig.
3B) (35).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 4.
Hydropathy and conservation profiles of the
GLY-2 protein sequence. TMD marks the peak corresponding to the
TMD, and the solid/dotted line indicates the
catalytic portion of the molecule as determined by experiments reported
here. The dotted portion of the line reflects that the
C-terminal extent of the catalytically critical region was not
investigated. A, Kyte-Doolittle profile generated using the
GCG Peptidestructure program using a window of 7 residues (51).
B, running similarity comparison to rat GlcNAc-TV
(GB:L14284) aligned using the GCG Gap program averaging over a window
of 25 residues. Alignment position refers to the numbering
of the alignment, not a specific residue in either polypeptide. Global
similarity is indicated by the dashed line. The
asterisk marks the position of the mislocalization point
mutations and the surrounding stretch of conserved residues.
|
|
GLY-2 Has GlcNAc-TV Enzymatic Activity--
Based on the
hydropathy and similarity profiles, we postulated that the N-terminal
limit of the catalytic domain is the boundary between exon 3 and 4, the
first junction after the C110-P124 peptide.
This is the equivalent region to that observed to be essential for
catalytic activity in rat GlcNAc-TV (36). Constructs directing the
secretion into the medium of soluble, truncated versions of the protein
(structures indicated in Fig. 3B) were transfected into Lec4
cells, a CHO-K1 derivative lacking endogenous GlcNAc-TV activity.
Transfections were incubated at 30 °C to reduce the anticipated
denaturation of GLY-2, which as a C. elegans enzyme is
adapted for growth at 20 °C. The resulting conditioned medium contained soluble fusion protein at ~1 µg/ml, and GlcNAc-TV
activity was detected from transfections with pISTH1-GLY2 series
plasmids but not from vector-only controls. The nematode enzyme is
markedly inhibited by NaCl above 50 mM (Fig.
5A). This is analogous to the
suppression of rat GlcNAc-TV by NaCl above physiological levels (37).
The pH optimum of GLY-2 is around pH 6.5 (Fig. 5B), typical of most Golgi glycosyltransferases, and is the ambient pH of the Golgi
apparatus (38). As expected GLY-2 is progressively thermolabile, and no
differences were apparent among truncation variants (Fig. 5C). As with other
6-N-acetylglucosaminyltransferases, GLY-2 was active in
the presence of EDTA, and Mn2+ addition did not stimulate
the reaction (data not shown).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 5.
Enzymatic properties of GLY-2 produced
by transient transfection of Lec4 cells. Assay temperature was
22 °C unless indicated otherwise. In panels A-E, data
are normalized to the negative control and maximal values.
A, effect of NaCl on the activity of dialyzed conditioned
medium from cells transfected with pISTH1::GLY2- 133.
B, pH profile of catalytic activity for conditioned medium
from cells transfected with pISTH1::GLY2- 27. Assays were
performed in 50 mM MES buffer of various pH values.
C, effect of temperature on the activity of conditioned
medium from cells transfected with pISTH1:: GLY2- 133.
D and E, effect of truncation at the N terminus
on catalytic activity of GLY2 fusion protein assayed in conditioned
medium or immunoprecipitates, respectively, from Lec4 cells transfected
with pISTH1::GLY2- 27, 133, 137, or 138. Data in
panels C-E are the mean of independent triplicates with
S.E. indicated by the error bars. F, specific
detection by Western blotting of appropriately sized recombinant GLY-2
in conditioned medium from cells transfected with
pISTH1::GLY2- 27.
|
|
Conditioned media from the truncation series containing equivalent
amounts of S-tag fusion protein were assayed directly (Fig. 5D). The inferred initiator methionine and
trans-membrane domain are confirmed by the detection of
soluble enzyme from the construct that lacked the first 27 deduced
residues. Deletion of more than 137 residues severely impaired the
specific activity. Since all truncation variants were equally
thermolabile, the most plausible reason is that the catalytic domain
boundary resides at Ile-138. To confirm this and demonstrate that
GlcNAc-TV activity was an intrinsic property of the recombinant
polypeptide, the fusion protein was immunoprecipitated from the
conditioned medium using anti-S-tag antibody. These assays were
performed with equivalent amounts of S-tagged fusion protein, allowing
direct comparisons between the various truncated forms (Fig.
5E). A band at the expected size (~81 kDa) was observed
when the immunoprecipitate of GLY-2
27 was Western-blotted for S-tag.
In the other truncations an unavoidable background band masked the
region at the expected size range (~60 kDa) (Fig. 5F). As
with conditioned medium, deleting the first 137 residues of GLY-2, a
region comprising the initiator methionine, the TMD, and the predicted
stem region, including the C110-P124 peptide,
had little effect on specific activity. Removing a single additional
residue reduced activity by 75%. Therefore, the boundary of the
catalytic domain does indeed correspond to the 5' limit of the exon
initiated by Ile-138.
gly-2 Can Rescue the Cell Surface Phenotype of Chinese Hamster
Ovary Lec4 Cells--
The complementation of a genetic defect by a
heterologous allele is a stringent test of equivalence since all the
salient properties of the endogenous gene must be fulfilled by the
introduced allele in the physiological environment. Lec4 mutant cells
lack GlcNAc-TV activity and the mature glycan products, GlcNAc
1,6 branched N-linked oligosaccharides on cell surface
glycoproteins, which can be specifically detected as determinants of
L-PHA binding (Fig.
6A). The parental phenotype
was restored to Lec4 by transfecting the wild-type CHO-K1 GlcNAc-TV
cDNA expression constructs (Fig. 6B). Transfection with
wild-type gly-2 also rescued the Lec4 phenotype, and the
profile is qualitatively identical to that of Lec4 cells rescued by
transfection of CHO-K1 GlcNAc-TV (Fig. 6D). The partially rescued population is probably the result of low levels of activity expressed in these cells, itself due to thermolability of the nematode
enzyme at 30 °C. Thus, gly-2 is functionally equivalent to the mammalian gene product, able to act on the natural glycoprotein substrates found in mammalian cells and create glycans recognized by L-PHA.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Rescue of the cell surface lectin binding
phenotype of Lec4 cells by transient transfection of
Ce-gly-2 or CHO-derived GlcNAc-TV constructs.
FITC fluorescence of CD20-positive live single cells is graphed.
A, the solid line is the profile of CHO-K1
parental cells, and the gray solid is the profile of Lec4
cells transfected with pLec4 plasmid. In panels B-D the
positions of the peak channel fluorescence of these samples is
indicated by the arrows. B, Lec4 cells
transfected with pCHO-K1. C, Lec4 cells transfected with
pCSYK-L116R. D, Lec4 cells transfected with pCSYK-1. Data
are representative of independent triplicates.
|
|
GlcNAc-TV must be present in the medial-Golgi because the
elaboration of
6-GlcNAc-branched N-glycans and Lec4A
mutant cells cannot bind L-PHA at the cell surface because
they mislocalize active enzyme (35). The equivalent of the Lec4A
missense mutation in GLY-2 was assayed. Protein truncations removing
this region are catalytically active, yet GLY-2(L116R) failed to rescue
the Lec4 phenotype in three independent experiments (Fig.
6C). Thus, although the wild-type GLY-2 enzyme complements
Lec4 and, therefore, must be expressed and functional, the L116R mutant
might not be. To address this, since attempts to raise anti-GLY-2
antibodies were unsuccessful, as were assays for activity in these
transfected samples, constructs expressing GFP fused to the N terminus
of GLY-2 were tested. Transfection of pEGFP-C3 alone does not affect the L-PHA binding properties of Lec4 or CHO-K1 (Fig.
7, A and B).
GFP::GLY-2(+), however, results in complete restoration of the parental phenotype in Lec4 cells and is more effective than native
GLY-2 (compare Figs. 7D to 6D). Consistent with
this enhancement, GFP::GLY-2(L116R) can now partially rescue
the cell surface phenotype and must therefore be catalytically
competent (compare Figs. 7C to 6C). The FACS
analysis indicated that transfection efficiencies were the same for all
samples; therefore, cell extracts were Western-blotted for GFP
epitopes, and GlcNAc-TV was assayed. Slightly more GFP epitope, as well
as GlcNAc-TV enzyme activity, can be detected per cell transfected with
GFP::GLY-2(L116R), but there is no indication of appreciable
differences in specific activity (Fig. 7, E and F). Transfected cells were examined by deconvolution
microscopy (data not shown), but fluorescent signals from both native
and mutant forms were present in membranous compartments other than medial-Golgi. Overexpression by transient transfection may
overwhelm retention and trafficking mechanisms, but nevertheless,
GLY-2(+) and GLY-2(L116R) have different rescue behaviors.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
Rescue of defective
L-PHA binding in Lec4 cells by transient
transfection with GFP fusions of Ce-GLY-2 or CHO
derived GlcNAc-TV constructs. Fluorescence from
CyChrome-streptavidin:biotin-L-PHA-stained GFP positive
live single cells is graphed. A, the profile of Lec4 cells
transfected with pEGFP-C3. B, CHO-K1 parental cells
transfected with pEGFP-C3. In panels C and D the
positions of the peak channel fluorescence of Lec4 and CHO-K1 from
A and B are indicated by the arrows.
C, Lec4 cells transfected with pEGFP-L116R. D,
Lec4 cells transfected with pEGFP-GLY2. Data are representative of
independent triplicates. E, immunoblot for GFP epitopes in
extracts from cells that were subjected to the FACS analysis shown in
panels C and D. Data are representative of
independent duplicates. The expected size of GFP::GLY-2 is
~107 kDa. F, GlcNAc-TV enzyme activity in the extracts
prepared as in E. The extract from the equivalent of
~8 × 105 cells was assayed for 3 h at 30 °C
in each case in the presence and absence of substrate to determine the
net incorporation of [6-3H]GlcNAc. Data are the mean of
independent duplicates with S.E. indicated by the error
bars.
|
|
Expression Pattern of gly-2p::GFP during Nematode
Development--
Transcriptional fusions of 6.7 kbp of upstream
genomic DNA corresponding to bases 19,280-25,991 of cosmid C55B7 to
nuclear localized and cytosolic forms of GFP provided by vectors
pPD95.69 and pPD95.77, respectively, were used as reporter constructs. This stretch includes the 3' end (base 19,436) of the next confirmed gene upstream on the same strand as gly-2. It encompasses
all of the 5'-untranslated region sequences found in yk126h8 (which starts at base 21,436) as well as the region that is conserved in the
genome of Caenorhabditis briggsae, a closely related species (alignment starts at base 23,114). By these criteria, the constructs should contain a fully qualified promoter of gly-2.
The distribution of signal in transgenic worms was unique and highly
restricted with respect to tissue and/or stage of development but did
not correspond to the descendants of a particular branch of the cell
lineage. Fluorescence was first detectable at the comma stage (Fig.
8A) in cells that divided and
appeared to migrate during the 2-fold (Fig. 8B) and 3-fold
stages (Fig. 8C). Neuronal staining was obvious from L1
onward and by early L4 was seen to occur in both the dorsal and ventral
nerve chords (Fig. 8D). During this stage, a strong signal
was noted in the developing vulva (most likely the vulE and/or vulF
cells). By late L4 an intense GFP signal in the spermathecal valve as
well as other vulval and/or uterine structures was evident (Fig.
8E). Expression in the uv1 and uv2 cells was suggested by
the pattern of fluorescence around the vulva. However, the
nuclear-localized reporter construct stained more nuclei than can be
accounted for by expression in these cells alone (Fig. 8F).
With this construct, nuclear localized signal was observed in all four
nuclei of the syncytial spermathecal valve cell (Fig. 8G).
Although GFP fluorescence was seen to be strongest in the late L4 and
early adult for the spermathecal valve and vulval/uterine structures
previously noted, it was seen to persist throughout adulthood (Fig.
8, H-J). The M8 cell of the terminal bulb of the pharynx,
all six cells of the pharyngeal-intestinal valve, and neuronal cell
bodies within the metacorpus and around the isthmus of the pharynx also
expressed gly-2p::GFP (Fig. 8K). At
least 37 neurons with cell bodies lying next to the ventral nerve chord
were positive for gly-2-directed reporter expression in the
adult hermaphrodite, although with widely varying levels of staining.
There was also GFP fluorescence present in other neurons associated
with the pre-anal, dorso-rectal, and/or lumbar ganglia. In adult males,
expression was similar in non-sexually dimorphic tissues and was also
observed in axons that project into rays 2, 3, 5, 6, and either 8 or 9 of the copulatory bursa (data not shown).

View larger version (106K):
[in this window]
[in a new window]
|
Fig. 8.
Pattern of gly-2
promoter-directed GFP expression during nematode
development. Except for panels F and G,
images are presented as pairs showing the epifluorescence from the
cytosolic GFP reporter in the upper section and differential
interference contrast images from the same field and focal
plane in the lower section. The emerald-green light is
emitted by GFP, the yellow-green signal is gut
autofluorescence. Scale bar in all cases is 20 µm.
A, comma stage embryo. B, 1.5-fold stage embryo.
C, 3-fold stage embryo. D, lateral view of an
early larval stage 4 hermaphrodite peri-vulval region. DNC,
dorsal nerve cord; VNC, ventral nerve cord; vul,
vulval cells vul E and/or vul F. E, ventral view of late
larval stage 4 hermaphrodite peri-vulval region. SV,
spermathecal valve; v/u, vulval and/or uterine structures.
F, as E, but from a nuclear-localized reporter.
G, detail in lateral view of the spermathecal valve staining
by the nuclear-localized reporter expressed in an adult hermaphrodite.
H, lateral view of an adult hermaphrodite mid-body showing
continued expression in the spermathecal valve (SV) and
vulval and/or uterine structures (v/u). I and
J, lateral views in two different focal planes from adult
hermaphrodites showing vulval/uterine staining (v/u).
K, lateral view of the pharynx from an adult hermaphrodite
showing GFP fluorescence from neurons (N) in the nerve ring
and ventral nerve chord (VNC) and the staining of the
pharyngeal-intestinal valve (PIV).
|
|
gly-2 Is a Non-essential Gene--
ev581 is a Tc1
insertion allele into the 7th intron of gly-2 from which
qa700 was derived by imprecise excision, an event that
deleted 1165 bp containing ~2.5 exons that contribute to the
catalytic domain (Table I).
qa703 is a deletion created by ethylmethanesulfonate-induced
deletion mutagenesis that removes 494 bp containing exon 6 and half of
the largest exon, 7, both of which contribute to the catalytic domain.
Both deletion alleles are probably null, but animals homozygous for
either are viable. To check that no gross rearrangements occurred
during mutagenesis, genetic mapping of the genotypes was performed.
This placed the alleles on linkage group I between 1.07 and 1.18 map
units to the right of dpy-5, exactly where expected from
interpolations of the physical map.
View this table:
[in this window]
[in a new window]
|
Table I
Genomic sequences of gly-2 alleles
Nucleotide numbering is the base position of the cosmid sequence C55B7
from the C. elegans sequencing consortium. Fusion junctions
in deletion alleles qa700 and qa703 are indicated
by double colons (::).
|
|
GlcNAc-TV activity could be detected in microsomal extracts of
wild-type C. elegans but not in the deletion mutant strain XA762 gly-2(qa703) (Fig. 9).
Enzyme activity was restored in transgenic lines carrying a genomic
region encompassing the gly-2 gene on the deletion mutant
background. Thus, gly-2, which is the sole cognate homologue
of Mgat-5 in C. elegans, encodes nematode
GlcNAc-TV.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 9.
GlcNAc-TV activity in C. elegans
is dependent on the gly-2 gene. N2 is the
laboratory wild-type strain; XA762 is homozygous for the
gly-2 deletion allele qa703. XA766 and XA768 are independent
strains carrying extrachromosomal arrays encompassing a
gly-2(+) genomic region on a gly-2(qa703)
background.
|
|
The strain XA728 gly-2(qa700**14) I
had fertility defects arising from abnormal sperm function (Spe) that
were not observed in XA762 gly-2(qa703**10) I. Compound heterozygotes of a qa700/qa703 genotype were non-Spe
confirming that this defect is caused by a linked but extragenic
mutation in a complementation group unrelated to gly-2 (data
not shown). Although gly-2 is expressed in many neurons, the
vulva, and spermatheca, XA762 was wild type with respect to morphology,
egg laying and hatching, locomotion, brood size, dauer
switching, male incidence, developmental timing, and mechanosensory
axon path-finding (data not shown). GFP reporter patterns were also
unaffected by the mutant background.
 |
DISCUSSION |
The genomic structure of the gly-2 gene is
significantly related to that of human GlcNAc-TV. The majority of exon
boundaries, particularly in the catalytic domain, occur at equivalent
residues and are in-frame. The N-terminal boundary of the catalytic
region starts at exon 4; exon 3 contains the "Lec4A" region.
Retention of phase zero introns in ancient genes is a feature of the
"introns-early" model (39). These observations support the notion
that exon shuffling of functional domains may have been the mechanism
by which the ancestral GlcNAc-TV gene originated.
The deduced polypeptide sequence of gly-2 is stereotypical
of Golgi glycosyltransferases, being a type II membrane protein with a 20-residue TMD starting six residues from the N terminus. This length is efficiently retained by the Golgi apparatus and is the
sole element in the polypeptide that appears to have bilayer-spanning properties (40). The lumenal portion starts with a hydrophilic region
that may position the following catalytic domain away from the membrane
and so promote efficient interactions with macromolecular substrates.
Heterologous expression of recombinant gene product demonstrated that
GLY-2 does indeed possess GlcNAc-TV enzyme activity and other
properties in common with the mammalian homologue. The putative
initiator codon and the TMD were confirmed since soluble recombinant
fusion proteins were produced when truncated. The proposed stem could
also be removed without affecting GlcNAc-TV enzyme activity in
vitro. Several other C. elegans
glycosyltransferase-related sequences have been found to possess the
catalytic activity expected from their homologies. gly-3,
gly-4, and gly-5 are polypeptide GalNAc-Ts (15),
and gly-12 and gly-14 encode active
GlcNAc-TI (16), whereas CeFT-1 is an
1,3-fucosyltransferase
(17). gly-1 and possibly the other core 2 GlcNAc-T
homologues may be an exception (23). GLY-1 transfers glucose rather
than GlcNAc to core 1 acceptors (24), an observation concordant with
the available structural data on C. elegans glycoprotein
glycans (22). The components of the proteoglycan pathway encoded by
sqv-3, sqv-7, and sqv-8 all possess
the biochemical activity expected from their homologies (20, 21). The
proper functioning of GlcNAc-TV depends not only on catalytic
competence but also upon being able to interact with nascent
glycoprotein substrates in the ambient milieu, correct localization,
and domain structure (35). We found unequivocally that gly-2
could rescue the surface lectin binding phenotype of Lec4 cells. Thus,
GLY-2 retains all of the salient properties of the mammalian GlcNAc-TV
despite being diverged for >500Myr (41).
Alignment of mammalian GlcNAc-TV and GLY-2 identified a region that is
highly conserved despite being N-terminal to the catalytic domain. This
region contains a leucine that is mutated in Lec4A cells, causing
otherwise active GlcNAc-TV to mislocalize and fail to elaborate
cell surface
6-GlcNAc-branched N-glycans in consequence (35). The equivalent mutation in native GLY-2 did not rescue the Lec4
defect, but a GFP fusion product could do so inefficiently. It may be
that the fusion protein is better expressed than the native nematode
enzyme in Lec4 cells or that the addition of GFP stabilizes the product
(42). The simplest interpretation is that GFP::GLY-2(L116R)
is mislocalized as in Lec4A, but due to overexpression typical of
transient transfections, a portion overwhelms the endoplasmic reticulum
retention system and proceeds to the medial-Golgi (43).
BLAST searches indicated that the conserved 15-residue peptide
encompassing the critical leucine is unique to GlcNAc-TV but has been
conserved throughout metazoan radiation. Because mutations affect
subcellular localization, it may be that the region is conserved
because of a role in targeting to the medial-Golgi. If so,
this mechanism is either GlcNAc-TV-specific or acts via its
conformational properties, plausible since the peptide is bounded by
two conserved cysteines. Conformational elements participate in the
subcellular localization of lysosomal hydrolases where a common surface
is recognized to initiate formation of the mannose
6-phosphate-targeting signal (44).
Our data are concordant with the dominant transcript being SL1
trans-spliced to the first splice acceptor upstream of the initiator codon and is typical of monocistronic C. elegans
genes with a proximal promoter (34). yk126h8 contains an additional 383 nucleotides that occur in 4 non-coding exons 3994-4533 bp upstream and
may represent a minor isoform from a distal upstream basal promoter.
Distal promoters driving expression of this type of transcript at low
levels are observed in C. elegans, for example pkc-1 (45). The genomic fragment used for constructing the
GFP reporter transgenes included both potential promoters. From these, GLY-2 expression can be crudely summarized as occurring in some of the
structures that have valve properties, the vulva, the spermathecal valve, and the pharyngeal-intestinal valve. The other major locus of
expression is neuronal, present in many but not all 302 neurons in the
adult hermaphrodite (46). Curiously, mammalian brain is rich in
GlcNAc-TV transcripts, but enzyme activity is barely detectable, and
Mgat-5o mice are not obviously affected (4).
However, failure to nurture pups is significantly more common in
Mgat-5o mice in a 129/Sv
background.3
The essentially complete sequence of the C. elegans genome
(8) contains a single gene that is orthologous to mammalian Golgi
GlcNAc-TV proteins at both the primary sequence and domain organization
level. This is unusual for glycosylation-related genes in the nematode.
The C. elegans genome contains many gene families, and
glycosyltransferases are well represented (14, 47, 48). Multiple
glycosyltransferase homologues, C-type and S-type lectin domains as
well as nucleotide-sugar synthases, occur in a cluster (49). Core 2 GlcNAc-T-like sequences are the 167th largest gene family (23, 48);
there are nine polypeptide GalNAc-T-like sequences (15), three
homologues of GlcNAc-TI (16), and evidence for at least two
1,3 fucosyltransferases (17). There are two
4-galactosyltransferase homologues, of which mutations in one, sqv-3, affects epithelial morphogenesis, resulting in
defects in vulval invagination as well as oocyte receptiveness to sperm (18, 19). Many mammalian glycosyltransferases are also present in
multiple copies (50), but as in the worm, GlcNAc-TV has only one
functional copy. Disruption of the Mgat-5 locus in mice
results in a complete loss of both enzyme activity and
GlcNAc
1,6-branched structures (4). Although structural studies have
yet to observe complex N-glycans in C. elegans,
GlcNAc-TV activity in wild-type animals is detectable, absent in
animals with gly-2 deleted, and restored by transgenes
containing gly-2 genomic DNA. From our present study, it
appears that Ce-gly-2 is orthologous to Mgat-5, structurally conserved at both genomic and polypeptide levels, and
functionally interchangeable with mammalian GlcNAc-TV. Such "deep
homology" is a feature of ancient and pivotal genes that occur in
conserved pathways (41), but ablation of the gly-2 gene in
C. elegans is without visible defects despite resulting in
an enzymatically null phenotype. This situation is not unusual; many
genes with severely defective alleles are viable in C. elegans (e.g. 23, 54). It may be that the contributions
are subtle under laboratory growth conditions.
Mgat-5o mice are also without overt phenotype
but display several phenotypes that are dependent on extrinsic
conditions. Suppression of tumor growth and metastasis induced by the
Polyomavirus middle T-antigen is observed (4)m and
abnormalities in T-cell function, although significant, do not appear
to compromise the animals greatly under laboratory conditions (3). The
tractability of screens in C. elegans to uncover synthetic
phenotypes enables this conundrum to be addressed and should mutate
genes that interact genetically with gly-2. These would
reveal GlcNAc-TV-dependent pathways and phenotypes,
identifying the contributions to fitness made by
6-GlcNAc-branched N-glycans.
 |
ACKNOWLEDGEMENTS |
We thank Lynda Doughty for DNA sequencing,
Giselle Knowles for FACS analyses, and John Hudson and Cindy
Todoroff for critical readings of the manuscript.
 |
FOOTNOTES |
*
This work was funded by a grant from the National Cancer
Institute of Canada.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF154122 (gly-2), AY037800 (cm20c4), and AY037802 (yk126h8). Appropriate data have also been contributed to ACeDB.
¶
Present address: Dept. of Developmental Biology and Genetics,
Stanford University, Palo Alto, CA 94305.
To whom correspondence should be addressed: Samuel Lunenfeld
Research Inst., Mount Sinai Hospital, 600 University Ave., Toronto, Ontario M5G 1X5, Canada. Tel.: 416-586-8233; Fax: 416-586-8857; E-mail:
dennis@mshri.on.ca.
Published, JBC Papers in Press, April 5, 2002, DOI 10.1074/jbc.M201390200
2
Y. Kohara et al., manuscript in preparation.
3
M. Granovsky, J. Pawling, P. Cheung, and J. W. Dennis, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
GlcNAc-TV, UDP-N-acetylglucosamine:
-6-D-mannoside
-1,6-N-acetylglucosaminyltransferase V;
L-PHA, P. vulgaris leucoagglutinin;
EST, expressed sequence tag;
FACS, fluorescence-activated cell analysis;
FITC, fluorescein isothiocyanate;
PBSE, PBS with 0.1% w/v EDTA;
PBSFN, PBS with 1% v/v fetal bovine serum and 0.1% w/v NaN3;
5'
RACE, rapid amplification of 5' cDNA ends;
SL1, splice leader type
1;
SL2, splice leader type 2;
TMD, trans-membrane domain;
BisTris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol;
MES, 2-(N-Morpholino)ethanesulfonic acid;
CHO, Chinese hamster
ovary;
GFP, green fluorescent protein;
TBS, Tris-buffered saline;
TBSTM, TBS with 0.1% v/v Tween 20 (TBST) and 5% skimmed milk;
MOPS, 3-(N-morpholino)propanesulfonic acid.
 |
REFERENCES |
| 1.
|
Dennis, J. W.,
Granovsky, M.,
and Warren, C. E.
(1999)
Bioessays
21,
412-421[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Granovsky, M.,
Fode, C.,
Warren, C. E.,
Campbell, R. M.,
Marth, J. D.,
Pierce, M.,
Fregien, N.,
and Dennis, J. W.
(1995)
Glycobiology
5,
797-806[Abstract/Free Full Text]
|
| 3.
|
Demetriou, M.,
Granovsky, M.,
Quaggin, S.,
and Dennis, J. W.
(2001)
Nature
409,
733-739[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Granovsky, M.,
Fata, J.,
Pawling, J.,
Muller, W. J.,
Khokha, R.,
and Dennis, J. W.
(2000)
Nat. Med.
6,
306-312[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Dennis, J. W.,
Laferte, S.,
Waghorne, C.,
Breitman, M. L.,
and Kerbel, R. S.
(1987)
Science
236,
582-585[Abstract/Free Full Text]
|
| 6.
|
Riddle, D. L., Blumenthal, T., Meyer, B. J., and Priess, J. R.
(eds)
(1997)
C. elegans II
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 7.
|
Wood, W. B.
(ed)
(1988)
The Nematode Caenorhabditis elegans
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 8.
|
The C. elegans Sequencing Consortium.
(1998)
Science
282,
2012-2018[Abstract/Free Full Text]
|
| 9.
|
Sternberg, P. W.,
and Han, M.
(1998)
Trends Genet.
14,
466-472[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Metzstein, M. M.,
Stanfield, G. M.,
and Horvitz, H. R.
(1998)
Trends Genet.
14,
410-416[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Wodarz, A.,
and Nusse, R.
(1998)
Annu. Rev. Cell Dev. Biol.
14,
59-88[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Padgett, R. W.,
Das, P.,
and Krishna, S.
(1998)
Bioessays
20,
382-390[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Greenwald, I.
(1998)
Genes Dev.
12,
1751-1762[Free Full Text]
|
| 14.
|
Campbell, J. A.,
Davies, G. J.,
Bulone, V.,
and Henrissat, B.
(1997)
Biochem. J.
326,
929-939[Medline]
[Order article via Infotrieve]
|
| 15.
|
Hagen, F. K.,
and Nehrke, K.
(1998)
J. Biol. Chem.
273,
8268-8277[Abstract/Free Full Text]
|
| 16.
|
Chen, S.,
Zhou, S.,
Sarkar, M.,
Spence, A. M.,
and Schachter, H.
(1999)
J. Biol. Chem.
274,
288-297[Abstract/Free Full Text]
|
| 17.
|
DeBose-Boyd, R. A.,
Nyame, A. K.,
and Cummings, R. D.
(1998)
Glycobiology
8,
905-917[Abstract/Free Full Text]
|
| 18.
|
Herman, T.,
and Horvitz, H. R.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
974-979[Abstract/Free Full Text]
|
| 19.
|
Herman, T.,
Hartwieg, E.,
and Horvitz, H. R.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
968-973[Abstract/Free Full Text]
|
| 20.
|
Bulik, D. A.,
Wei, G.,
Toyoda, H.,
Kinoshita-Toyoda, A.,
Waldrip, W. R.,
Esko, J. D.,
Robbins, P. W.,
and Selleck, S. B.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
10838-10843[Abstract/Free Full Text]
|
| 21.
|
Berninsone, P.,
Hwang, H. Y.,
Zemtseva, I.,
Horvitz, H. R.,
and Hirschberg, C. B.
(2001)
Proc. N |